CRVL vs WTW: CorVel and Willis Towers Watson compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- Willis Towers Watson is the larger company, worth $29.2B, about 7.5 times CorVel.
- CorVel grew revenue faster over the last year (+10.7% vs +9.1%).
- On earnings, Willis Towers Watson is the cheaper stock (18.1x vs 37.2x).
- CorVel's price assumes faster free cash flow growth: about 12% a year, against 4% for Willis Towers Watson (reverse DCF).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CRVL | WTW |
|---|---|---|
| Market cap | $3.9B | $29.2B |
| Share price | $77.16 | $296.26 |
| Revenue (last fiscal year) | $959M | $9.7B |
| Free cash flow (last fiscal year) | $110M | $1.5B |
| Revenue growth, last year | +10.7% | +9.1% |
| Revenue growth per year, last 5 fiscal years | +10.4% | +1.9% |
| Operating margin | — | 22.2% |
| Net margin | 11.7% | 15.5% |
| Return on equity | 28.2% | 20.4% |
| P/E (trailing) | 37.2x | 18.1x |
| Price / free cash flow | 42.4x | 18.9x |
| EV / EBITDA | 20.3x | 12.7x |
| FCF growth the price implies | 12.4% | 4.2% |
| Dividend yield | — | 0.90% |
| Debt / equity | 0.69x | 2.96x |
| Fundamental grade | C | C |
| Superinvestors holding it | 2 | 11 |
| Insider purchases, last 12 months | 0 | 0 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
CorVel
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2022 | $646M | $37M | — |
| 2023 | $719M | $56M | — |
| 2024 | $795M | $70M | — |
| 2025 | $896M | $92M | — |
| 2026 | $959M | $110M | — |
Willis Towers Watson
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $9.0B | $2.0B | 24.5% |
| 2022 | $8.9B | $746M | 13.3% |
| 2023 | $9.5B | $1.0B | 14.4% |
| 2024 | $9.9B | $1.2B | 6.3% |
| 2025 | $9.7B | $1.5B | 23.0% |
Where the revenue comes from
CorVel · by products, 2026
Patient Management Services$597M62%
Network Solutions Services$362M38%
Willis Towers Watson · by segments, 2025
HWC$5.3B56%
R&B$4.2B44%
Corporate$3M0%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CRVL in InvestinglyQuestions
Which is bigger, CorVel or Willis Towers Watson?
Willis Towers Watson (WTW), at $29.2B against $3.9B.
Is CRVL or WTW cheaper?
By trailing P/E, Willis Towers Watson (18.1x) is cheaper than CorVel (37.2x). A lower multiple can also mean the market expects less growth.
Which grows faster, CRVL or WTW?
CorVel: revenue grew +10.7% over the last year, against +9.1%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.